Fitness Bio Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 2

Fitness Bio General Information

Description

Developer of Innovative and generic drug development designed to mitigate illness symptoms. The company focuses on developing and researching innovative drug in areas include connective tissue diseases and cerebrovascular diseases, providing advanced medical solution for patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • No. 319, Xiangjiang Road, Shijiazhuang High-tech Zone
  • 6-501
  • Shijiazhuang, Hebei 050035
  • China
+86 150
Primary Industry
Drug Discovery
Other Industries
Other Healthcare Services
Corporate Office
  • No. 319, Xiangjiang Road, Shijiazhuang High-tech Zone
  • 6-501
  • Shijiazhuang, Hebei 050035
  • China
+86 150

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Fitness Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC 07-Jul-2023 Completed Generating Revenue
1. Later Stage VC 28-Jan-2022 Completed Generating Revenue
To view Fitness Bio’s complete valuation and funding history, request access »

Fitness Bio Patents

Fitness Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2026062990-A Use of se-dr affinitive peptides for the preparation of a medicament for treating rheumatic diseases Pending 30-Jul-2021
EP-4378471-A1 Use of se-dr affinity peptide in preparing drug for treating rheumatic disease Pending 30-Jul-2021
EP-4378471-A4 Use of se-dr affinity peptide in preparing drug for treating rheumatic disease Pending 30-Jul-2021
US-20250074946-A1 Use of se-dr affinity peptide in preparing drug for treating rheumatic disease Pending 30-Jul-2021
WO-2023006125-A1 Use of se-dr affinity peptide in preparing drug for treating rheumatic disease Inactive 30-Jul-2021 C07K14/001
To view Fitness Bio’s complete patent history, request access »

Fitness Bio Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Shanghai Junquanxin Investment Venture Capital Minority
Chiron Ventures Venture Capital Minority
To view Fitness Bio’s complete investors history, request access »

Fitness Bio FAQs

  • When was Fitness Bio founded?

    Fitness Bio was founded in 2010.

  • Where is Fitness Bio headquartered?

    Fitness Bio is headquartered in Shijiazhuang, China.

  • What industry is Fitness Bio in?

    Fitness Bio’s primary industry is Drug Discovery.

  • Is Fitness Bio a private or public company?

    Fitness Bio is a Private company.

  • What is Fitness Bio’s current revenue?

    The current revenue for Fitness Bio is .

  • Who are Fitness Bio’s investors?

    Shanghai Junquanxin Investment and Chiron Ventures have invested in Fitness Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process